despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..: "targeted cgrp small molecule antagonists for acute migraine therapy.".
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..: "targeted cgrp small molecule antagonists for acute migraine therapy.".